Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $113,365,653    

Indirect Value

   $155,367,900      
Total Shares   53,734,364      
Total Value   $268,733,553      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,382,743 Rapt Therapeutics, Inc. $23,479,172 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $87,503,738 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,382,743 Rapt Therapeutics, Inc. $23,479,172 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $87,503,738 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,610,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-12 4 B $14.00 $104,989 I/I 7,500 15,815,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-30 4 B $13.91 $123,195 I/I 8,855 16,121,727 2.25 -
TNYA Tenaya Therapeutics, Inc. Director   –       •       •   2023-01-17 4 B $2.49 $123,395 I/I 49,463 9,664,847 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-05 4 B $18.00 $149,526 I/I 8,307 16,802,351 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-14 4 B $14.00 $150,687 I/I 10,760 15,837,474 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-11 4 B $13.83 $150,718 I/I 10,900 15,807,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-11 4 B $13.87 $150,752 I/I 10,870 15,894,961 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-10-17 4 B $3.18 $159,140 D/D 50,000 130,000 3.92 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-13 4 B $14.13 $162,508 I/I 11,500 15,826,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-04 4 B $4.72 $165,320 I/I 35,058 339,845 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-24 4 B $13.78 $168,650 I/I 12,240 15,884,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-04 4 B $13.39 $168,764 I/I 12,600 15,771,614 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-06 4 B $13.40 $168,884 I/I 12,600 15,784,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-07 4 B $13.66 $172,176 I/I 12,600 15,796,814 2.25 -
TNYA Tenaya Therapeutics, Inc. Director   –       •       •   2023-01-19 4 B $2.50 $174,201 I/I 69,739 9,870,274 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,794,044 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2022-11-21 4 B $5.00 $179,942 I/I 35,997 375,842 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-03 4 B $12.41 $181,025 I/I 14,587 17,660,648 2.25 %
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-09 4 B $10.26 $181,848 I/I 17,724 16,374,631 1.5 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-02 4 B $12.40 $184,140 I/I 14,850 17,646,061 2.25 %
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-10 4 B $10.50 $186,102 I/I 17,724 16,392,355 1.5 -
NGM Ngm Biopharmaceuticals In... 10% Owner   –       –       •   2019-10-11 4 B $10.57 $187,343 I/I 17,724 16,410,079 1.5 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-19 4 B $13.91 $211,674 I/I 15,214 15,852,688 2.25 -
  145  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us